BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 307981)

  • 1. Serum copper and zinc measurement in patients with osteogenic sarcoma.
    Breiter DN; Diasio RB; Neifeld JP; Roush ML; Rosenberg SA
    Cancer; 1978 Aug; 42(2):598-602. PubMed ID: 307981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper and zinc levels in serum from human patients with sarcomas.
    Fisher GL; Byers VS; Shifrine M; Levin AS
    Cancer; 1976 Jan; 37(1):356-63. PubMed ID: 764964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper and zinc levels in melanoma patients.
    Fisher GL; Spitler LE; McNeill KL; Rosenblatt LS
    Cancer; 1981 Apr; 47(7):1838-44. PubMed ID: 7226078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of copper and zinc in patients with lung cancer].
    Altavilla G; Adamo V; Alafaci E; Buemi B; Chillemi S; La Scala R; Marabello G; Palmara D
    Minerva Med; 1985 Nov; 76(44):2117-20. PubMed ID: 4069424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
    Sanada S; Ogura K; Kiriyama T; Yoshida O
    Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum copper and zinc content in non-small cell lung cancer: abnormalities and clinical correlates.
    Ferrigno D; Buccheri G; Camilla T
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):204-8. PubMed ID: 10441970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum copper and zinc levels in patients with cervical cancer.
    Chen CA; Hwang JL; Kuo TL; Hsieh CY; Huang SC
    J Formos Med Assoc; 1990 Aug; 89(8):677-82. PubMed ID: 1981230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum copper and zinc levels in patients with nasopharyngeal carcinoma.
    Lian SL; Hsu HY; Lin SM
    Taiwan Yi Xue Hui Za Zhi; 1989 Mar; 88(3):236-9. PubMed ID: 2794920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
    Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
    Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck.
    Garofalo JA; Erlandson E; Strong EW; Lesser M; Gerold F; Spiro R; Schwartz M; Good RA
    J Surg Oncol; 1980; 15(4):381-6. PubMed ID: 7453188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of trace elements by proton induced X-ray emission (PIXE) in serum of patients with liver cancer and normal subjects].
    Liu XM
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):411-3. PubMed ID: 3015527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions.
    Garofalo JA; Ashikari H; Lesser ML; Menendez-Botet C; Cunningham-Rundles S; Schwartz MK; Good RA
    Cancer; 1980 Dec; 46(12):2682-5. PubMed ID: 7448705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The determination of Cu and Zn levels in the serum and gastric juice of patients with gastric cancer].
    Wang CS
    Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):401-3, 444. PubMed ID: 2598740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
    Beattie EJ; Martini N; Rosen G
    Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy.
    Hsu HY; Lin SY; Huang CJ; Lian SL; Ho YH
    Biol Trace Elem Res; 1994; 46(1-2):1-13. PubMed ID: 7888274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.